INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME: CLINICAL IMPLICATIONS AND IMPACT ON QUALITY OF LIFE — A NARRATIVE REVIEW
Authors:
- Martyna SienickaMSMartyna Sienicka
- Weronika WiniarskaWWWeronika Winiarska
- Wiktoria Bełcikowska-SkowronWBWiktoria Bełcikowska-Skowron
- Aleksandra SiegmundASAleksandra Siegmund
- Marzena ChrapczyńskaMCMarzena Chrapczyńska
- Agnieszka FilareckaAFAgnieszka Filarecka
- Piotr PrzybyszewskiPPPiotr Przybyszewski
- Emilia PrzybyszewskaEPEmilia Przybyszewska
- Julia GatniejewskaJGJulia Gatniejewska
- Paulina PrudzicPPPaulina Prudzic
Open Access
- 16 August 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Abstract
Polycystic ovary syndrome (PCOS) is a multifaceted endocrine and metabolic condition affecting women of reproductive age. While historically conceptualized as a reproductive disorder, current evidence indicates that PCOS extends beyond ovulatory dysfunction and hyperandrogenism to include significant metabolic, psychological, and quality of life consequences. Insulin resistance represents a core pathophysiological feature of the syndrome, contributing to hyperinsulinemia, exacerbation of androgen excess, menstrual irregularities, and long term metabolic risk. This narrative review synthesizes current literature on the mechanisms and clinical implications of insulin resistance in PCOS, drawing from peer reviewed studies, systematic reviews, meta analyses, and international guidelines. Evidence shows that insulin resistance is prevalent across PCOS phenotypes, including in women without obesity, and is strongly associated with impaired glucose metabolism, dyslipidemia, metabolic syndrome, and increased cardiometabolic vulnerability. Psychological burden is also substantial, with many women reporting depressive and anxiety symptoms, body image concerns, fertility related distress, and reduced overall wellbeing. Interactions between metabolic dysfunction, emotional health, and lifestyle factors further contribute to diminished health related quality of life. Collectively, these findings highlight the need for early metabolic assessment, individualized therapeutic strategies, and interdisciplinary care models addressing both physiological and psychosocial dimensions of PCOS. A comprehensive approach to insulin resistance may improve reproductive, metabolic, and psychological outcomes and support more patient centered long term management.Keywords
This publication has 30 references indexed in Scilit:
- Insulin resistance and PCOS: chicken or egg?Journal of Endocrinological Investigation, 2020
- Polycystic ovary syndrome: definition, aetiology, diagnosis and treatmentNature Reviews Endocrinology, 2018
- Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityCochrane Database of Systematic Reviews, 2017
- Polycystic ovary syndromeNature Reviews Disease Primers, 2016
- Lifestyle changes in women with polycystic ovary syndromeCochrane Database of Systematic Reviews, 2011
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosisNature Reviews Endocrinology, 2011
- The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy SubjectsMetabolic Syndrome and Related Disorders, 2008
- Increased risk of depressive disorders in women with polycystic ovary syndromeFertility and Sterility, 2007
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985